Ravada Kishore
University of Hyderabad
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ravada Kishore.
Bioorganic & Medicinal Chemistry Letters | 2012
Ali Nakhi; Raju Adepu; D. Rambabu; Ravada Kishore; G.R. Vanaja; Arunasree M. Kalle; Manojit Pal
Novel thieno[3,2-c]pyran-4-one based small molecules were designed as potential anticancer agents. Expeditious synthesis of these compounds was carried out via a multi-step sequence consisting of few steps such as Gewald reaction, Sandmeyer type iodination, Sonogashira type coupling followed by iodocyclization and then Pd-mediated various C-C bond forming reactions. The overall strategy involved the construction of thiophene ring followed by the fused pyranone moiety and then functionalization at C-7 position of the resultant thieno[3,2-c]pyran-4-one framework. Some of the compounds synthesized showed selective growth inhibition of cancer cells in vitro among which two compounds for example, 5d and 6c showed IC(50) values in the range of 2.0-2.5 μM. The crystal structure analysis of an active compound along with hydrogen bonding patterns and molecular arrangement present within the molecule is described.
Bioorganic & Medicinal Chemistry Letters | 2012
Ali Nakhi; Md. Shafiqur Rahman; Ravada Kishore; Chandana Lakshmi T. Meda; Girdhar Singh Deora; Kishore V. L. Parsa; Manojit Pal
2-Substituted pyrrolo[2,3-b]quinoxalines having free NH were prepared directly from 3-alkynyl-2-chloroquinoxalines in a single pot by using readily available and inexpensive methane sulfonamide (or p-toluene sulfonamide) as an ammonia surrogate. The reaction proceeded in the presence of Cu(OAc)(2) affording the desired product in moderate yield. The crystal structure analysis of a representative compound and its supramolecular interactions are presented. Some of the compounds synthesized exhibited inhibitory activities against luciferase that was supported by the predictive binding mode of these compounds with luciferase enzyme through molecular docking studies. The key observations disclosed here can alert users of luciferase reporter gene assays for possible false positive results due to the direct inhibition of luciferase.
Bioorganic & Medicinal Chemistry Letters | 2013
Ali Nakhi; P.T.V.A. Srinivas; Md. Shafiqur Rahman; Ravada Kishore; Guru Pavan Kumar Seerapu; K. Lalith Kumar; Devyani Haldar; M.V. Basaveswara Rao; Manojit Pal
A rapid, inexpensive and high yielding method has been developed for the synthesis of 1,8-dioxodecahydroacridines using Amberlite IR-120H as a reusable catalyst under open air. These compounds were designed as potential inhibitors of sirtuins and prepared via the MCR of 5,5-dimethyl-1,3-cyclohexanedione, (hetero)aryl aldehydes and (hetero)aromatic amines under mild conditions. Further structure elaboration of a representative compound was performed via Pd catalyzed C-C bond forming reactions. The crystal structure analysis and H-bonding patterns along with in vitro inhibitory activity against yeast Sir2 of the same compound is presented. Docking studies indicated that the compound interacts well with the yeast Sir2.
Bioorganic & Medicinal Chemistry Letters | 2013
Ali Nakhi; Md. Shafiqur Rahman; Sivakumar Archana; Ravada Kishore; Guru Pavan Kumar Seerapu; K. Lalith Kumar; Devyani Haldar; Manojit Pal
Novel pyrano[4,3-b]pyran-5(4H)-one based small molecules were designed as potential inhibitors of sirtuins (i.e., yeast sir2, a homolog of human SIRT1). Elegant synthesis of these compounds was performed via a multi-step sequence consisting of MCR, Sandmeyer type iodination, Sonogashira type coupling followed by iodocyclization and then Pd-mediated various C-C bond forming reactions. The overall strategy involved the construction of a pyran ring followed by the fused pyranone moiety and subsequent functionalization at C-8 position of the resultant core pyrano[4,3-b]pyran-5(4H)-one framework. The crystal structure analysis of a representative iodolactonized product (6d) is presented. Some of the synthesized compounds showed promising inhibitory activities when tested against yeast sir2 in vitro. The compound 6g showed dose dependent inhibition (IC50=78.05μM) of yeast sir2 and good interactions with this protein in silico.
CrystEngComm | 2015
Vedichi Madhu; Supriya Sabbani; Ravada Kishore; Indravath K. Naik; Samar K. Das
An organic receptor [C28H24N4]2+ can be obtained with its unusual cis-form when it is ion-paired with a [Zn(dmit)2]2− coordination complex anion with the isolation of [C28H24N4][Zn(dmit)2]·2DMF (2). Compound 2 shows reversible cis–trans isomerization of the cationic receptor in a solid to solid transformation in a solid–liquid interface reaction.
Polyhedron | 2010
Bharat Kumar Tripuramallu; Ravada Kishore; Samar K. Das
Inorganica Chimica Acta | 2011
Bharat Kumar Tripuramallu; Ravada Kishore; Samar K. Das
Crystal Growth & Design | 2012
Ravada Kishore; Samar K. Das
Journal of Molecular Structure | 2013
Ravada Kishore; Samar K. Das
Inorganica Chimica Acta | 2010
Ramababu Bolligarla; Ravada Kishore; Gummadi Durgaprasad; Samar K. Das